BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS

被引:1096
|
作者
FUTREAL, PA
LIU, QY
SHATTUCKEIDENS, D
COCHRAN, C
HARSHMAN, K
TAVTIGIAN, S
BENNETT, LM
HAUGENSTRANO, A
SWENSEN, J
MIKI, Y
EDDINGTON, K
MCCLURE, M
FRYE, C
WEAVERFELDHAUS, J
DING, W
GHOLAMI, Z
SODERKVIST, P
TERRY, L
JHANWAR, S
BERCHUCK, A
IGLEHART, JD
MARKS, J
BALLINGER, DG
BARRETT, JC
SKOLNICK, MH
KAMB, A
WISEMAN, R
机构
[1] MYRIAD GENET,SALT LAKE CITY,UT 84108
[2] UNIV UTAH,MED CTR,DEPT MED INFORMAT,SALT LAKE CITY,UT 84123
[3] FAC HLTH SCI LINKOPING,DEPT OCCUPAT MED,S-58185 LINKOPING,SWEDEN
[4] MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021
[5] DUKE UNIV,MED CTR,DEPT GYNECOL ONCOL,DURHAM,NC 27710
[6] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
关键词
D O I
10.1126/science.7939630
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Loss of heterozygosity data from familial tumors suggest that BRCA1, a gene that confers susceptibility to ovarian and early-onset breast cancer, encodes a tumor suppressor. The BRCA1 region is also subject to allelic loss in sporadic breast and ovarian cancers, an indication that BRCA1 mutations may occur somatically in these tumors. The BRCA1 coding region was examined for mutations in primary breast and ovarian tumors that show allele loss at the BRCA1 locus. Mutations were detected in 3 of 32 breast and 1 of 12 ovarian carcinomas; all four mutations were germline alterations and occurred in early-onset cancers. These results suggest that mutation of BRCA1 may not be critical in the development of the majority of breast and ovarian cancers that arise in the absence of a mutant germline allele.
引用
收藏
页码:120 / 122
页数:3
相关论文
共 50 条
  • [41] Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer
    Ui-Soon Khoo
    Hilmi Ozcelik
    Annie NY Cheung
    Louis WC Chow
    Hextan YS Ngan
    Susan J Done
    A C T Liang
    Vivian WY Chan
    Gordon KH Au
    Wing-Fung Ng
    Cycles SP Poon
    Yuet-Foon Leung
    Florence Loong
    Philip Ip
    Gavin SW Chan
    Irene L Andrulis
    Jing Lu
    Faith CS Ho
    Oncogene, 1999, 18 : 4643 - 4646
  • [42] Mutations of the BRCA1 gene in hereditary breast and ovarian cancer in the Czech Republic
    Pohlreich, P
    Stríbrná, J
    Kleibl, Z
    Zikán, M
    Kalbácová, R
    Petruzelka, L
    Konopásek, B
    MEDICAL PRINCIPLES AND PRACTICE, 2003, 12 (01) : 23 - 29
  • [43] BRCA1 gene mutations in patients with both breast and ovarian cancer.
    Naldi, N
    Zanelli, P
    Bella, MA
    Michiarn, M
    Bozzetti, C
    Cengarle, R
    ANNALS OF ONCOLOGY, 2000, 11 : 33 - 33
  • [44] BRCA1 germline mutations in Chinese patients with hereditary breast and ovarian cancer
    Li, N
    Zhang, X
    Cai, Y
    Xu, X
    Zhang, L
    Pan, KF
    Wu, LY
    Wang, MR
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 172 - 178
  • [45] BRCA1 mutations in breast cancer: identification of new mutations in the BRCA1 gene in Algerian population
    Salhi, Nadjet
    Gargouri, Raja
    Bakour, Rabah
    Nacer, Benzidane
    Boulgua, Kada
    Guargouri, Ali
    Farid, Cherbal
    CANCER RESEARCH, 2006, 66 (08)
  • [46] BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers
    Shih, HA
    Nathanson, KL
    Seal, S
    Collins, N
    Stratton, MR
    Rebbeck, TR
    Weber, BL
    CLINICAL CANCER RESEARCH, 2000, 6 (11) : 4259 - 4264
  • [47] Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
    Golmard, L.
    Delnatte, C.
    Lauge, A.
    Moncoutier, V.
    Lefol, C.
    Abidallah, K.
    Tenreiro, H.
    Copigny, F.
    Giraudeau, M.
    Guy, C.
    Barbaroux, C.
    Amorim, G.
    Briaux, A.
    Guibert, V.
    Tarabeux, J.
    Caputo, S.
    Collet, A.
    Gesta, P.
    Ingster, O.
    Stern, M-H
    Rouleau, E.
    De Pauw, A.
    Gauthier-Villars, M.
    Buecher, B.
    Bezieau, S.
    Stoppa-Lyonnet, D.
    Houdayer, C.
    ONCOGENE, 2016, 35 (10) : 1324 - 1327
  • [48] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Benais-Pont, Gaelle
    Maillet, Philippe
    DISEASE MARKERS, 2010, 28 (06) : 377 - 384
  • [49] Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients
    Aydemir, AEM
    Luleci, G
    Ozcelik, T
    Colak, T
    Schayek, H
    Akaydin, M
    Friedman, E
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 387 - 387
  • [50] Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
    Moran, A.
    O'Hara, C.
    Khan, S.
    Shack, L.
    Woodward, E.
    Maher, E. R.
    Lalloo, F.
    Evans, D. G. R.
    FAMILIAL CANCER, 2012, 11 (02) : 235 - 242